Financial BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update byTim AllenMay 14, 2025
Spine Top Stories Stryker announces definitive agreement for the sale of its U.S. spinal implants business and plans to sell related international business byJosh SandbergJanuary 29, 2025
Recon Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies byTim AllenSeptember 9, 2024
Biologics Spine Top Stories Orthofix Names Max Reinhardt President of Global Spine Business byJosh SandbergMay 23, 2024
Financial Bioretec Ltd’s business review January-March 2024: Controlled launch in the U.S. progresses byTim AllenMay 16, 2024
Financial Neuro Assure Holdings Closes Sale of Certain Assets to MPOWERHealth byJosh SandbergMarch 28, 2024
Biologics Spine Top Stories Orthofix Announces New President for Bone Growth Therapies Business byJosh SandbergFebruary 29, 2024
Financial Spine Top Stories Centinel Spine® Record prodisc® Total Disc Replacement Growth of 55% in 2023 Sets the Foundation for Continued Growth in 2024 and Beyond byJosh SandbergJanuary 31, 2024
Biologics Financial Spine Top Stories Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer byJosh SandbergJanuary 8, 2024
